Abstract A030: Human papilloma virus awareness among non-Hispanics, U.S.-born Hispanics, and foreign-born Hispanics, United States, 2017-2018
Authors: Escobar Betsy , Amboree Trisha , Jibaja-Weiss Maria , Montealegre Jane 
Published: September 2020

Abstract
Introduction: Hispanics are the largest and fastest growing minority in the U.S. Knowledge of Human Papilloma Virus (HPV), and the HPV vaccine is reportedly lower among Hispanics compared to non-Hispanic whites. However, the Hispanic population is not homogenous, and there may be significant differences among subpopulations (e.g., by country/region of origin). We examined HPV knowledge and awareness among non-Hispanics (NH), U.S. born Hispanics (USH), and Foreign-born Hispanics (FBH). Methods: We analyzed data from the Health Information National Trends Survey (HINTS) 5 cycle 1 (2017) and cycle 2 (2018). HINTS is a nationally representative cross-sectional sample of health media use and cancer-related knowledge among U.S. adults. Using SAS Version 9.4, we conducted Wald Chi-Square tests to attain descriptive statistics. We performed a multivariate logistic regression to assess the association between two parallel outcomes – (1) heard about HPV and (2) heard of the HPV vaccine, and the primary predictors – Hispanic ethnicity and nativity while controlling for sociodemographic factors. Results: The majority of FBH (92.57%) had been in the U.S. for more than 10 years. A higher proportion of both FBH (68.75%) and USH (67.17%) reported having an immediate family member between 9 and27 years old compared to NH (47.39%). A lower percentage of FBH (48.61%) had heard of HPV compared to USH (67.60%) and NH (64.73%). A lower percentage of FBH (47.74%) had heard of the HPV-vaccine compared to USH (55.71%) and NH (64.48%). In multivariable analyses, FBH had 44% (odds ratio [OR] = 0.56, confidence interval [CI] = 0.36 – 0.85) lower odds of having heard of HPV and USH had 42% (OR = 0.58, CI = 0.43 – 0.78) lower odds of having heard of HPV vaccine compared to NH after adjusting for sociodemographic factors. Additionally, being female, older in age, having some college education or higher, and household income of $35K-49,999 or &gt;$75K were significantly associated with having heard of HPV and the HPV vaccine (p&lt;0.0001). Conclusion: There are differences between FBH and USH in levels of HPV awareness. Within these subgroups, a disconnect exists regarding awareness of HPV and the HPV-vaccine. FBH were more aware of HPV but not as much about the HPV-vaccine while USH were less aware of HPV but more aware of the HPV-vaccine. Overall low level of awareness of HPV and the HPV vaccine is concerning given that a large proportion of USB and FHB have a vaccine-eligible family member 9-27 years old. Strategic HPV awareness campaigns are needed to target the different subgroups among Hispanics based on their nativity status.
Citation Format: Betsy Escobar, Trisha Amboree, Maria Jibaja-Weiss, Jane Montealegre. Human papilloma virus awareness among non-Hispanics, U.S.-born Hispanics, and foreign-born Hispanics, United States, 2017-2018 [abstract]. In: Proceedings of the Twelfth AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2019 Sep 20-23; San Francisco, CA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2020;29(6 Suppl_2):Abstract nr A030.